◆英語タイトル:Asahi Kasei Pharma Corp - Strategic SWOT Analysis Review
◆商品コード:GDPH135987SA
◆発行会社(調査会社):
GlobalData
◆発行日:2020年12月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Asahi Kasei Pharma Corp – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights
Asahi Kasei Pharma Corp (Asahi Kasei Pharma), a subsidiary of Asahi Kasei Corp, manufactures and markets diagnostic reagents, prescription drugs, and enzymes for diagnostic reagents. Its prescription drugs are used for the treatment of osteoporosis pain, disseminated intravascular coagulation, bone loss, dysuria accompanying benign prostatic hyperplasia, nocturia, proteinuria in nephrotic syndrome and lupus nephritis, among others. Asahi Kasei Pharma offers assay kits for glycemic control and to detect prediabetes. The company’s pipeline products are intended for the treatment of chemotherapy-induced peripheral neuropathy, osteoporosis with high risk of fracture, Lupus nephritis and nephrotic syndrome and severe sepsis with coagulopathy, among others. It has facilities in Shizuoka, and Nagoya, Japan. Asahi Kasei Pharma is headquartered in Tokyo, Japan.
Asahi Kasei Pharma Corp Key Recent Developments
Nov 18,2020: Asahi Kasei Pharma contracts ProBioGen for the advancement of their biologics pipeline
Oct 13,2020: Asahi Kasei Pharma to solicit proposals for drug discovery research
Aug 05,2020: Asahi Kasei providing samples of hyaluronic acid nanogel as a new pharmaceutical excipient
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Asahi Kasei Pharma Corp – Key Facts
Asahi Kasei Pharma Corp – Key Employees
Asahi Kasei Pharma Corp – Major Products and Services
Asahi Kasei Pharma Corp – History
Asahi Kasei Pharma Corp – Company Statement
Asahi Kasei Pharma Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Asahi Kasei Pharma Corp – Business Description
Asahi Kasei Pharma Corp – SWOT Analysis
SWOT Analysis – Overview
Asahi Kasei Pharma Corp – Strengths
Asahi Kasei Pharma Corp – Weaknesses
Asahi Kasei Pharma Corp – Opportunities
Asahi Kasei Pharma Corp – Threats
Asahi Kasei Pharma Corp – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Asahi Kasei Pharma Corp, Recent Deals Summary
Section 4 – Company’s Recent Developments
Nov 18, 2020: Asahi Kasei Pharma contracts ProBioGen for the advancement of their biologics pipeline
Oct 13, 2020: Asahi Kasei Pharma to solicit proposals for drug discovery research
Aug 05, 2020: Asahi Kasei providing samples of hyaluronic acid nanogel as a new pharmaceutical excipient
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Asahi Kasei Pharma Corp, Key Facts
Asahi Kasei Pharma Corp, Key Employees
Asahi Kasei Pharma Corp, Major Products and Services
Asahi Kasei Pharma Corp, History
Asahi Kasei Pharma Corp, Other Locations
Asahi Kasei Pharma Corp, Subsidiaries
Asahi Kasei Pharma Corp, Key Competitors
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Asahi Kasei Pharma Corp, Recent Deals Summary